rs2296291
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002293.4(LAMC1):c.855-114C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.558 in 735,432 control chromosomes in the GnomAD database, including 116,817 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.52 ( 21031 hom., cov: 32)
Exomes 𝑓: 0.57 ( 95786 hom. )
Consequence
LAMC1
NM_002293.4 intron
NM_002293.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.562
Publications
9 publications found
Genes affected
LAMC1 (HGNC:6492): (laminin subunit gamma 1) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), have a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 1. The gamma 1 chain, formerly thought to be a beta chain, contains structural domains similar to beta chains, however, lacks the short alpha region separating domains I and II. The structural organization of this gene also suggested that it had diverged considerably from the beta chain genes. Embryos of transgenic mice in which both alleles of the gamma 1 chain gene were inactivated by homologous recombination, lacked basement membranes, indicating that laminin, gamma 1 chain is necessary for laminin heterotrimer assembly. It has been inferred by analogy with the strikingly similar 3' UTR sequence in mouse laminin gamma 1 cDNA, that multiple polyadenylation sites are utilized in human to generate the 2 different sized mRNAs (5.5 and 7.5 kb) seen on Northern analysis. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 1-183110374-C-T is Benign according to our data. Variant chr1-183110374-C-T is described in ClinVar as Benign. ClinVar VariationId is 1250945.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.63 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LAMC1 | ENST00000258341.5 | c.855-114C>T | intron_variant | Intron 3 of 27 | 1 | NM_002293.4 | ENSP00000258341.3 | |||
| LAMC1 | ENST00000484114.2 | c.-31-114C>T | intron_variant | Intron 3 of 3 | 3 | ENSP00000473583.1 | ||||
| LAMC1 | ENST00000479499.1 | n.-207C>T | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.517 AC: 78531AN: 151884Hom.: 20978 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
78531
AN:
151884
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.569 AC: 331706AN: 583430Hom.: 95786 AF XY: 0.571 AC XY: 172177AN XY: 301598 show subpopulations
GnomAD4 exome
AF:
AC:
331706
AN:
583430
Hom.:
AF XY:
AC XY:
172177
AN XY:
301598
show subpopulations
African (AFR)
AF:
AC:
5196
AN:
14338
American (AMR)
AF:
AC:
14116
AN:
21226
Ashkenazi Jewish (ASJ)
AF:
AC:
6872
AN:
14176
East Asian (EAS)
AF:
AC:
19691
AN:
31824
South Asian (SAS)
AF:
AC:
23845
AN:
36906
European-Finnish (FIN)
AF:
AC:
25143
AN:
42672
Middle Eastern (MID)
AF:
AC:
1968
AN:
3694
European-Non Finnish (NFE)
AF:
AC:
218365
AN:
389086
Other (OTH)
AF:
AC:
16510
AN:
29508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
6895
13790
20684
27579
34474
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3578
7156
10734
14312
17890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.517 AC: 78634AN: 152002Hom.: 21031 Cov.: 32 AF XY: 0.524 AC XY: 38918AN XY: 74290 show subpopulations
GnomAD4 genome
AF:
AC:
78634
AN:
152002
Hom.:
Cov.:
32
AF XY:
AC XY:
38918
AN XY:
74290
show subpopulations
African (AFR)
AF:
AC:
15521
AN:
41444
American (AMR)
AF:
AC:
9453
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1720
AN:
3472
East Asian (EAS)
AF:
AC:
3165
AN:
5168
South Asian (SAS)
AF:
AC:
3130
AN:
4820
European-Finnish (FIN)
AF:
AC:
6358
AN:
10536
Middle Eastern (MID)
AF:
AC:
164
AN:
294
European-Non Finnish (NFE)
AF:
AC:
37463
AN:
67962
Other (OTH)
AF:
AC:
1156
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1907
3814
5722
7629
9536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2232
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.